Neupro 6 mg/24 hours transdermal system Images
Generic Name: rotigotine
This medication has been identified as Neupro 6 mg/24 hours transdermal system. It is supplied by UCB, Inc.
Neupro is used in the treatment of Restless Legs Syndrome; Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Neupro 6 mg/24 hours transdermal system is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Neupro
- Generic Name
- rotigotine
- Strength
- 6 mg/24 hours transdermal system
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- UCB, Inc.
- National Drug Code (NDC)
- 50474-0805
See also:
Requip
Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors and muscle ...
Mirapex
Mirapex (pramipexole) treats the symptoms of Parkinson's disease and is also used to treat Restless ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Horizant
Horizant (gabapentin enacarbil) is used to treat restless legs syndrome and nerve pain caused by ...
Inbrija
Inbrija is an inhaled medicine used to treat the symptoms of Parkinson's disease. Includes side ...
Requip XL
Requip XL is used for parkinson's disease, periodic limb movement disorder
Gabapentin enacarbil
Gabapentin enacarbil is used for alcohol use disorder, postherpetic neuralgia, restless legs syndrome
Levodopa
Levodopa is used for parkinson's disease, parkinsonism, periodic limb movement disorder, restless ...
Pramipexole
Pramipexole is used for parkinson's disease, periodic limb movement disorder, restless legs ...
More about Neupro (rotigotine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (73)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.